Stem-Cell Derived Exosomal microRNAs as Biomarkers and Therapeutics for Pediatric Cardiovascular Disease DOI Creative Commons
Aaron H. Wasserman,

Bana Abolibdeh,

Reema Hamdan

et al.

Current Treatment Options in Cardiovascular Medicine, Journal Year: 2025, Volume and Issue: 27(1)

Published: April 9, 2025

In recent years, several pre-clinical studies have demonstrated the therapeutic potential of stem cell-derived exosomes in treatment cardiovascular disease (CVD). Here, we evaluate their as biomarkers for detection and monitoring CVD, with a particular focus on pediatric heart disease. Exosomes isolated from cell sources, including mesenchymal cells (MSCs) pluripotent (PSCs), benefit function, inflammatory responses, angiogenesis injured diseased hearts. These carry variety cargo, such proteins, lipids, nucleic acids. However, majority contain non-coding RNA molecules. Review existing literature RNAs relationship to CVD suggests that containing microRNAs (miRNAs) can serve promising due presence circulation, ease isolation, potential. are especially screening diagnostic tools early congenital

Language: Английский

Exosome nanovesicles: A potential carrier for therapeutic delivery DOI Creative Commons
Vivek P. Chavda, Anjali Pandya, Lalit Kumar

et al.

Nano Today, Journal Year: 2023, Volume and Issue: 49, P. 101771 - 101771

Published: Feb. 7, 2023

Exosomes are small nanosized biovesicles that form when multivesicular bodies and the plasma membrane fuse released into surrounding body fluids. They best known for their multifunction in mediating intercellular communication by transferring various biomolecules, including DNA, RNAs, proteins, lipids, a short- long-distance manner have been identified as health disease messengers. Importantly, exosomes necessary physiological processes disease. The generation of depends on status disease, which usually exhibits opposite roles inducing enhanced cellular stress damage. Recently, exosome-based nanotechnologies provided unprecedented opportunities to boost developments exosome-related biology, chemistry, pathology, therapeutics different diseases based unique structural/compositional/morphological characteristics next-generation nanomedicines. Herein, we provide comprehensive overview recent advances exosome nanotechnology research, classification, isolation preparation, constitution, biological function, nanobiomedical applications treatment diagnosis. Furthermore, future prospects were also concluded. This review will more inspiration promoting development advanced theranostic nanoplatforms nanotechnology.

Language: Английский

Citations

86

Interdisciplinary fetal-neonatal neurology training applies neural exposome perspectives to neurology principles and practice DOI Creative Commons
Mark S. Scher

Frontiers in Neurology, Journal Year: 2024, Volume and Issue: 14

Published: Jan. 15, 2024

An interdisciplinary fetal-neonatal neurology (FNN) program over the first 1,000 days teaches perspectives of neural exposome that are applicable across life span. This curriculum strengthens neonatal neurocritical care, pediatric, and adult training objectives. Teaching at maternal-pediatric hospital centers optimally merges reproductive, pregnancy, pediatric approaches to healthcare. Phenotype–genotype expressions health or disease pathways represent a dynamic developmental time. The science uncertainty applied FNN re-enforces importance shared clinical decisions minimize bias reduce cognitive errors. Trainees select mentoring committee participants will maximize their learning experiences. Standardized questions oral presentations monitor educational progress. Master doctoral defense preparation competitive research funding can be goals for specific individuals. principles practice offer an understanding gene–environment interactions recognizes effects reproductive on maternal-placental-fetal triad, neonate, child, adult. Pre-conception prenatal adversities potentially diminish life-course brain health. Endogenous exogenous toxic stressor interplay (TSI) alters through maladaptive neuroplasticity. Developmental disorders epilepsy primarily expressed during days. Communicable noncommunicable illnesses continue interact with express diverse neurologic lifespan, particularly critical/sensitive time periods adolescence senescence. Anomalous destructive fetal neuropathologic lesions change this developmental-aging continuum. integrated placental, neonatal, childhood, offers perspective exposome. Exosome promises improved monitoring drug delivery starting pregnancy. origins anticipate diagnoses interventions benefit successive generations. Addressing care disparities in Global South high-income country medical deserts require constructive dialogue among stakeholders achieve equity. Population policies capital strategy reduces global burden diseases by applying practice. integrative approach prolong survival quality persons lifespan confronted neurological disorders.

Language: Английский

Citations

22

Therapeutic Strategy of Mesenchymal-Stem-Cell-Derived Extracellular Vesicles as Regenerative Medicine DOI Open Access

Yasunari Matsuzaka,

Ryu Yashiro

International Journal of Molecular Sciences, Journal Year: 2022, Volume and Issue: 23(12), P. 6480 - 6480

Published: June 9, 2022

Extracellular vesicles (EVs) are lipid bilayer membrane particles that play critical roles in intracellular communication through EV-encapsulated informative content, including proteins, lipids, and nucleic acids. Mesenchymal stem cells (MSCs) pluripotent with self-renewal ability derived from bone marrow, fat, umbilical cord, menstruation blood, pulp, etc., which they use to induce tissue regeneration by their direct recruitment into injured tissues, the heart, liver, lung, kidney, or secreting factors, such as vascular endothelial growth factor insulin-like factor. Recently, MSC-derived EVs have been shown regenerative effects against various diseases, partially due post-transcriptional regulation of target genes miRNAs. Furthermore, garnered attention novel drug delivery systems, because can specially encapsulate molecules. In this review, we summarize molecular mechanisms EVs.

Language: Английский

Citations

63

Exploring the Versatility of Exosomes: A Review on Isolation, Characterization, Detection Methods, and Diverse Applications DOI

Özge Altıntaş,

Yeşeren Saylan

Analytical Chemistry, Journal Year: 2023, Volume and Issue: 95(44), P. 16029 - 16048

Published: Oct. 24, 2023

Extracellular vesicles (EVs) are crucial mediators of intercellular communication and can be classified based on their physical properties, biomolecular structure, origin. Among EVs, exosomes have garnered significant attention due to potential as therapeutic diagnostic tools. Exosomes released via fusion multivesicular bodies plasma membranes isolated from various biofluids using methods such differential ultracentrifugation, immune affinity capture, ultrafiltration, size exclusion chromatography. Herein, an overview different techniques for exosome characterization isolation, well the diverse applications detection, including use in drug delivery disease diagnosis, is provided. Additionally, we discuss emerging field detection by sensors, which offers up-and-coming avenue point-of-care tools development. Overall, this review aims provide a exhaustive up-to-date summary current state research.

Language: Английский

Citations

39

MiR-519d-3p from Placenta-Derived Exosomes Induce Immune Intolerance Regulating Immune Cells, Contributing to the Pathogenesis of Preeclampsia DOI Creative Commons

Siqi Cao,

Tingting Jiang, Yingying Guo

et al.

Immunological Investigations, Journal Year: 2025, Volume and Issue: unknown, P. 1 - 22

Published: Jan. 17, 2025

Background MiR-519d-3p, also called specific placenta biomarkers, is a member of the Chromosome 19 miRNA Cluster (C19MC) with highest concentrations miRNAs in human and maternal serum. These are secreted by fetal trophoblast cells within extracellular vesicles (EVs) interact mother's immune cells, which has been proposed to be crucial for immunological tolerance at placental-maternal interface. A key mechanism preeclampsia, multifactorial, multipath hypertensive pregnancy illness, an imbalance between mother fetus.

Language: Английский

Citations

1

Placental Exosomes as Biomarkers for Maternal Diseases: Current Advances in Isolation, Characterization, and Detection DOI
Minh Nguyen, Mohamed Sallam, Md. Sajedul Islam

et al.

ACS Sensors, Journal Year: 2023, Volume and Issue: 8(7), P. 2493 - 2513

Published: July 14, 2023

Serving as the interface between fetal and maternal circulation, placenta plays a critical role in growth development. Placental exosomes are small membrane-bound extracellular vesicles released by during pregnancy. They contain variety of biomolecules, including lipids, proteins, nucleic acids, which can potentially be biomarkers diseases. An increasing number studies have demonstrated utility placental for diagnosis monitoring pathological conditions such pre-eclampsia gestational diabetes. This suggests that may serve new liquid biopsy analysis. review provides an overview current understanding biological function their potential Additionally, this highlights barriers way forward standardization validation known techniques exosome isolation, characterization, detection. Finally, microfluidic devices research discussed.

Language: Английский

Citations

18

Quality and Safety Considerations for Therapeutic Products Based on Extracellular Vesicles DOI Creative Commons
Yoshinobu Takakura, Rikinari Hanayama, Kazunari Akiyoshi

et al.

Pharmaceutical Research, Journal Year: 2024, Volume and Issue: 41(8), P. 1573 - 1594

Published: Aug. 1, 2024

Extracellular vesicles (EVs) serve as an intrinsic system for delivering functional molecules within our body, playing significant roles in diverse physiological phenomena and diseases. Both native engineered EVs are currently the subject of extensive research promising therapeutics drug delivery systems, primarily due to their remarkable attributes, such targeting capabilities, biocompatibility, low immunogenicity mutagenicity. Nevertheless, clinical application is still a long way off owing multiple limitations. In this context, Science Board Pharmaceuticals Medical Devices Agency (PMDA) Japan has conducted comprehensive assessment identify current issues related quality safety EV-based therapeutic products. Furthermore, we have presented several examples state-of-the-art methodologies employed EV manufacturing, along with guidelines critical processes, production, purification, characterization, evaluation control, assessment, development therapeutics. These endeavors aim facilitate pave transformative impact healthcare.

Language: Английский

Citations

8

Extracellular vesicles in bacterial and fungal diseases – Pathogenesis to diagnostic biomarkers DOI Creative Commons
Apoorva Jnana,

S. S. Sadiya,

Kapaettu Satyamoorthy

et al.

Virulence, Journal Year: 2023, Volume and Issue: 14(1)

Published: Feb. 16, 2023

Intercellular communication among microbes plays an important role in disease exacerbation. Recent advances have described small vesicles, termed as "extracellular vesicles" (EVs), previously disregarded "cellular dust" to be vital the intracellular and intercellular host-microbe interactions. These signals been known initiate host damage transfer of a variety cargo including proteins, lipid particles, DNA, mRNA, miRNAs. Microbial EVs, referred generally "membrane (MVs), play key exacerbation suggesting their importance pathogenicity. Host EVs help coordinate antimicrobial responses prime immune cells for pathogen attack. Hence with central microbe-host communication, may serve diagnostic biomarkers microbial pathogenesis. In this review, we summarize current research regarding roles markers pathogenesis specific focus on interaction defence potential conditions.

Language: Английский

Citations

15

Exploring the role of exosomal MicroRNAs as potential biomarkers in preeclampsia DOI Creative Commons

Yuping Shan,

Bo Hou, Jingli Wang

et al.

Frontiers in Immunology, Journal Year: 2024, Volume and Issue: 15

Published: March 19, 2024

The complex pathogenesis of preeclampsia (PE), a significant contributor to maternal and neonatal mortality globally, is poorly understood despite substantial research. This review explores the involvement exosomal microRNAs (exomiRs) in PE, focusing on their impact protein kinase B (AKT)/hypoxia-inducible factor 1-α (HIF1α)/vascular endothelial growth (VEGF) signaling pathway as well cell proliferation migration. Specifically, this article amalgamates existing evidence reveal pivotal role exomiRs regulating mesenchymal stem trophoblast function, placental angiogenesis, renin–angiotensin system, nitric oxide production, which may contribute PE etiology. emphasizes limited knowledge regarding while underscoring potential non-invasive biomarkers for diagnosis, prediction, treatment. Further, it provides valuable insights into mechanisms highlighting key players with clinical implications, warranting further exploration enhance current understanding development novel therapeutic interventions.

Language: Английский

Citations

6

Placenta-targeted Treatment Strategies for Preeclampsia and Fetal Growth Restriction: An Opportunity and Major Challenge DOI Creative Commons

Jianjian Cui,

Zejun Yang,

Ruilin Ma

et al.

Stem Cell Reviews and Reports, Journal Year: 2024, Volume and Issue: 20(6), P. 1501 - 1511

Published: May 30, 2024

Abstract The placenta plays a crucial role in maintaining normal pregnancy. failure of spiral artery remodeling (SAR) is key factor leading to placental ischemia and poor perfusion which strongly associated with obstetric diseases, including preeclampsia (PE) fetal growth restriction (FGR). Existing interventions for PE FGR are limited termination pregnancy inevitable when the maternal or fetus condition deteriorates. Considering safety mother fetus, treatments that may penetrate barrier harm not accepted. Developing targeted treatment strategies these conditions urgent necessary. With proven efficacy therapy treating such as endometrial cancer trophoblastic tumors, research on dysfunction continues deepen. This article reviews studies placenta-targeted drug delivery strategies, summarizes characteristics proposes corresponding improvement measures treatment, provides solutions existing problems, makes suggestions future studies. Graphical abstract

Language: Английский

Citations

5